复方制剂-话题@MedSci

#复方制剂#

30篇内容 | 1779人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2223871, encodeId=351b22238e1be, content=<a href='/topic/show?id=b20e698513' target=_blank style='color:#2F92EE;'>#ESC#</a> <a href='/topic/show?id=3231981537e' target=_blank style='color:#2F92EE;'>#降压药#</a> <a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=降压效果，一片顶三片！复方制剂有效控制82%患者血压 | 2024 ESC, objectType=article, longId=841622, objectId=f18f8416229a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720277147515_5579292.png, objectUrl=/article/show_article.do?id=f18f8416229a, replyNumber=0, likeNumber=69, createdTime=2024-09-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f18f8416229a, moduleTitle=降压效果，一片顶三片！复方制剂有效控制82%患者血压 | 2024 ESC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f18f8416229a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197054, encodeId=7e43219e05490, content=<a href='/topic/show?id=07f25183043' target=_blank style='color:#2F92EE;'>#心血管疾病#</a> <a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=心血管风险降低50%！他汀&阿司匹林复方制剂或为新选择, objectType=article, longId=819076, objectId=3a498190e668, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021540666_4754896.webp, objectUrl=/article/show_article.do?id=3a498190e668, replyNumber=0, likeNumber=62, createdTime=2024-04-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=3a498190e668, moduleTitle=心血管风险降低50%！他汀&阿司匹林复方制剂或为新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a498190e668)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1601068, encodeId=b637160106887, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=NEJM：多药复方制剂在心血管二级预防中的应用, objectType=article, longId=739386, objectId=c599e3938671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c599e3938671, replyNumber=0, likeNumber=69, createdTime=2022-09-17, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c599e3938671, moduleTitle=NEJM：多药复方制剂在心血管二级预防中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c599e3938671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601067, encodeId=df3f160106e65, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=NEJM：单片复方制剂能降低心肌梗死后患者心血管事件复发（SECURE试验）, objectType=article, longId=737183, objectId=2239e3718311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2239e3718311, replyNumber=0, likeNumber=110, createdTime=2022-08-29, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2239e3718311, moduleTitle=NEJM：单片复方制剂能降低心肌梗死后患者心血管事件复发（SECURE试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2239e3718311)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601066, encodeId=952b16010660a, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=60年来首次！FDA批准重度抑郁口服速效药物Auvelity（右美沙芬与安非他酮缓释复方制剂），1周起效！, objectType=article, longId=736474, objectId=0ecce36474e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ecce36474e6, replyNumber=0, likeNumber=105, createdTime=2022-08-22, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ecce36474e6, moduleTitle=60年来首次！FDA批准重度抑郁口服速效药物Auvelity（右美沙芬与安非他酮缓释复方制剂），1周起效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ecce36474e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601065, encodeId=1489160106503, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=Arch Dermatol Res：钙泊三醇-倍他米松复方制剂治疗银屑病的临床疗效和安全性分析, objectType=article, longId=733989, objectId=12c2e339898e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12c2e339898e, replyNumber=0, likeNumber=0, createdTime=2022-08-01, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12c2e339898e, moduleTitle=Arch Dermatol Res：钙泊三醇-倍他米松复方制剂治疗银屑病的临床疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12c2e339898e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601064, encodeId=9a9d160106487, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=「复方制剂降压药」该怎样用？一文理清！, objectType=article, longId=733920, objectId=9779e33920c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9779e33920c1, replyNumber=0, likeNumber=95, createdTime=2022-07-31, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9779e33920c1, moduleTitle=「复方制剂降压药」该怎样用？一文理清！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9779e33920c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601063, encodeId=bda81601063d6, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=目前中国**BB+CCB长效单片复方制剂上市！促进中国高血压治疗血压心率双管理！, objectType=article, longId=219177, objectId=f3342191e7d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3342191e7d0, replyNumber=0, likeNumber=57, createdTime=2021-10-25, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3342191e7d0, moduleTitle=目前中国**BB+CCB长效单片复方制剂上市！促进中国高血压治疗血压心率双管理！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3342191e7d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601062, encodeId=7a4916010621b, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, objectType=article, longId=213502, objectId=ee6b2135028f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6b2135028f, replyNumber=0, likeNumber=74, createdTime=2021-07-01, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6b2135028f, moduleTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6b2135028f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601061, encodeId=0161160106178, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=从指南到实践：采用复方制剂的起始降压治疗, objectType=article, longId=206028, objectId=283720602886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=283720602886, replyNumber=0, likeNumber=0, createdTime=2021-01-23, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=283720602886, moduleTitle=从指南到实践：采用复方制剂的起始降压治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=283720602886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601060, encodeId=e0f716010608d, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=国家药监局：以临床价值为导向，推动古代经典名方中药复方制剂研制, objectType=article, longId=205249, objectId=27c32052494e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27c32052494e, replyNumber=0, likeNumber=82, createdTime=2021-01-04, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27c32052494e, moduleTitle=国家药监局：以临床价值为导向，推动古代经典名方中药复方制剂研制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27c32052494e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601059, encodeId=ae9d160105934, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=3款复方制剂通过一致性评价，来自华东医药、福元医药…, objectType=article, longId=200843, objectId=006420084354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=006420084354, replyNumber=0, likeNumber=68, createdTime=2020-09-19, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=006420084354, moduleTitle=3款复方制剂通过一致性评价，来自华东医药、福元医药…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=006420084354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601058, encodeId=43e1160105805, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=中国抗青光眼药物复方制剂使用的专家共识（2019年）, objectType=article, longId=179460, objectId=f2681e94604d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2681e94604d, replyNumber=0, likeNumber=64, createdTime=2019-09-16, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2681e94604d, moduleTitle=中国抗青光眼药物复方制剂使用的专家共识（2019年）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2681e94604d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601057, encodeId=6046160105e98, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=Lancet发表伊朗研究称，每天一片复方制剂，可有效预防心血管病, objectType=article, longId=178651, objectId=dd1c1e8651f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1c1e8651f7, replyNumber=0, likeNumber=72, createdTime=2019-09-04, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1c1e8651f7, moduleTitle=Lancet发表伊朗研究称，每天一片复方制剂，可有效预防心血管病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1c1e8651f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601056, encodeId=e1ce160105688, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=三部门：将含羟考酮复方制剂等品种列入精神药品管理, objectType=article, longId=177111, objectId=f5c01e7111a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5c01e7111a0, replyNumber=0, likeNumber=85, createdTime=2019-08-08, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5c01e7111a0, moduleTitle=三部门：将含羟考酮复方制剂等品种列入精神药品管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5c01e7111a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601055, encodeId=69251601055fb, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=药监局公开征求古代经典名方中药复方制剂意见, objectType=article, longId=163097, objectId=b06216309e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b06216309e6d, replyNumber=0, likeNumber=102, createdTime=2019-03-29, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b06216309e6d, moduleTitle=药监局公开征求古代经典名方中药复方制剂意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b06216309e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601054, encodeId=fef1160105484, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=培哚普利/吲达帕胺固定剂量复方制剂降压治疗中国专家共识, objectType=article, longId=161604, objectId=188016160496, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=188016160496, replyNumber=0, likeNumber=69, createdTime=2019-03-05, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=188016160496, moduleTitle=培哚普利/吲达帕胺固定剂量复方制剂降压治疗中国专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=188016160496)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601053, encodeId=b1fa160105347, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=病例分享 |“西甲”固定复方制剂，降糖界的“黄金搭档”！, objectType=article, longId=151634, objectId=5a451516341d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a451516341d, replyNumber=0, likeNumber=62, createdTime=2018-10-24, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a451516341d, moduleTitle=病例分享 |“西甲”固定复方制剂，降糖界的“黄金搭档”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a451516341d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601052, encodeId=64b8160105267, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=《古代经典名方中药复方制剂简化注册审批管理规定》出台！, objectType=article, longId=139955, objectId=5a3a139955f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a3a139955f1, replyNumber=0, likeNumber=85, createdTime=2018-06-06, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a3a139955f1, moduleTitle=《古代经典名方中药复方制剂简化注册审批管理规定》出台！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a3a139955f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601051, encodeId=c85f1601051fc, content=<a href='/topic/show?id=dd43426460c' target=_blank style='color:#2F92EE;'>#复方制剂#</a>, objectTitle=ACC 2018：TRIUMPH研究：初始小剂量固定复方制剂可提高降压达标率, objectType=article, longId=132574, objectId=3bfc1325e47a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bfc1325e47a, replyNumber=0, likeNumber=82, createdTime=2018-03-17, rootId=0, userName=chengjn, userId=279318829047, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bfc1325e47a, moduleTitle=ACC 2018：TRIUMPH研究：初始小剂量固定复方制剂可提高降压达标率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bfc1325e47a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复方制剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#ESC# #降压药# #复方制剂#

降压效果，一片顶三片！复方制剂有效控制82%患者血压 | 2024 ESC

2024-09-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#心血管疾病# #复方制剂#

心血管风险降低50%！他汀&阿司匹林复方制剂或为新选择

2024-04-05发表于陕西省

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

NEJM：多药复方制剂在心血管二级预防中的应用

2022-09-17

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

NEJM：单片复方制剂能降低心肌梗死后患者心血管事件复发（SECURE试验）

2022-08-29

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

60年来首次！FDA批准重度抑郁口服速效药物Auvelity（右美沙芬与安非他酮缓释复方制剂），1周起效！

2022-08-22

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

Arch Dermatol Res：钙泊三醇-倍他米松复方制剂治疗银屑病的临床疗效和安全性分析

2022-08-01

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

「复方制剂降压药」该怎样用？一文理清！

2022-07-31

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

目前中国**BB+CCB长效单片复方制剂上市！促进中国高血压治疗血压心率双管理！

2021-10-25

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究

2021-07-01

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

从指南到实践：采用复方制剂的起始降压治疗

2021-01-23

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

国家药监局：以临床价值为导向，推动古代经典名方中药复方制剂研制

2021-01-04

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

3款复方制剂通过一致性评价，来自华东医药、福元医药…

2020-09-19

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

中国抗青光眼药物复方制剂使用的专家共识（2019年）

2019-09-16

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

Lancet发表伊朗研究称，每天一片复方制剂，可有效预防心血管病

2019-09-04

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

三部门：将含羟考酮复方制剂等品种列入精神药品管理

2019-08-08

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

药监局公开征求古代经典名方中药复方制剂意见

2019-03-29

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

培哚普利/吲达帕胺固定剂量复方制剂降压治疗中国专家共识

2019-03-05

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

病例分享 |“西甲”固定复方制剂，降糖界的“黄金搭档”！

2018-10-24

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

《古代经典名方中药复方制剂简化注册审批管理规定》出台！

2018-06-06

chengjn (审核中...)

前往app查看评论内容

#复方制剂#

ACC 2018：TRIUMPH研究：初始小剂量固定复方制剂可提高降压达标率

2018-03-17

科室
- - 订阅+
  - 更多科室
工具
服务